News | 02 July 2012
We aim at becoming a "global pharmaceutical company specializing in specific fields (ophthalmology and dermatology) and developing and selling pharmaceutical products through the eyes of doctors." We are promoting the development of new drugs for ...
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)